Episode 56 - Eeva Broberg - RSV - A Winter Threat To The Vulnerable

ECDC: On Air

European Centre for Disease Prevention and Control

Science

5 • 3 Ratings

🗓️ 18 December 2024

⏱️ 20 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

In this interview, we sit down with Eeva Broberg, ECDC Principal Expert on respiratory viruses, who tells us why respiratory syncytial virus (RSV) is an often overlooked disease which represents a considerable risk to certain groups every winter.

Eeva also talks about the impact on healthcare, and whether current treatments like monoclonal antibodies and the introduction of vaccines in Europe are a game changer.

Read more about RSV on the European Vaccination Information Portal: vaccination-info.europa.eu/en/rsv

Transcript

Click on a timestamp to play from that location

0:00.0	ECDC On Air, the podcast of the European Center for Disease Prevention and Control.
0:09.0	Keeping up to date with European Epidemiology.
0:13.0	Welcome to today's episode of ECDC on Air, which is the podcast for the European Center for Disease Prevention and Control. Today I have with me in the studio Eva Broberi, who is a microbiologist and one of ECDC's
0:26.6	principal experts on respiratory viruses. Eva is here to tell us more about RSV, which is a virus
0:32.6	that may not be as familiar to many people as other respiratory viruses such as COVID or flu.
0:38.3	Nonetheless, it's a virus that can be serious, especially for certain risk groups.
0:42.3	So, Eva, welcome to the studio here.
0:59.6	Thank you for having me.
1:00.9	Can you start off a bit by telling us the basics of RSV?
1:04.4	What are the symptoms and how does it spread?
1:06.7	So RSV is one of the respiratory viruses.
1:09.9	It's called respiratory syncytile virus.
1:13.9	It causes mostly common cold type symptoms.
1:18.8	But it can cause also very severe conditions.
1:21.9	For elderly or for infants, for newborns, it can be rather severe.
1:26.9	And it can cause bron bronchiitis or pneumonia.
1:30.1	It can even cause death.
1:31.7	But of course in Europe, we have very good health care.
1:34.8	So the mortality is higher for RSV in low-income countries.
1:39.8	In Europe, we have a lot of supportive care and most of the cases are saved.
1:45.8	But of course, the lower respiratory infections can become very severe and the patient could
1:53.3	end up in intensive care and might need mechanical ventilation, for example, and RSV can cause death.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from European Centre for Disease Prevention and Control, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of European Centre for Disease Prevention and Control and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.